ABSTRACT
Objective Estimates of influenza vaccine use are not available at the county level for U.S. nursing home (NH) residents but are critically necessary to guide implementation of quality improvement programs aimed at increasing vaccination rates. Furthermore, estimates that account for differences in resident characteristics between counties are unavailable. We estimated risk-standardized vaccination rates among short- and long-stay NH residents by U.S. county and identified drivers of geographic variation.
Methods We conducted a retrospective cohort study utilizing 100% of 2013-2015 fee-for-service Medicare claims, Minimum Data Set assessments, Certification and Survey Provider Enhanced Reports, and LTCFocUS. We separately evaluated short-stay (<100 days) and long-stay (≥100 days) residents aged ≥65 years old across the 2013-2014 and 2014-2015 influenza seasons. We estimated county-level risk-standardized vaccination rates (RSVRs) via hierarchical logistic regression adjusting for 32 resident-level covariates. We then used multivariable linear regression models to assess associations between county-level NHs predictors and RSVRs.
Results The overall study cohort consisted of 2,817,217 residents in 14,658 NHs across 2,798 counties. Short-stay residents had lower RSVRs than long-stay residents (2013-2014: median [IQR], 69.6% [62.8-74.5] vs 84.0% [80.8-86.4]). Counties with the highest vaccination rates were concentrated in the Midwestern, Southern, and Northeast US. Several modifiable facility-level characteristics were associated with increased RSVRs, including higher registered nurse to total nurse ratio and higher total staffing for licensed practical nurses, speech language pathologists, and social workers. Characteristics associated with lower RSVRs included higher percentage of residents restrained, with a pressure ulcer, and NH-level hospitalizations per resident-year.
Conclusions Substantial county-level variation in influenza vaccine use exists among short- and long-stay NH residents. Quality improvement interventions to improve vaccination rates can leverage these results to target NHs located in counties with lower risk-standardized vaccine use.
Competing Interest Statement
J.B.B.S., E.B., M.R.R., P.M., B.H.B., R.B., and A.R.Z. declare no conflicts of interest. R.v.A., M.M.L., and A.C. are employed by Sanofi Pasteur. K.W.M reports grants from Seqirus Pharmaceuticals, Sanofi Pasteur and Pfizer related to pneumococcal pneumonia and influenza vaccination in the long-term care setting., S.G. reports grants from Seqirus Pharmaceuticals, Sanofi Pasteur; and consulting or speaker fees from Sanofi, Seqirus, Merck, Longeveron, and the Gerontological Society of America related to vaccines or nursing home care quality.
Funding Statement
This Brown University collaborative research was funded by Sanofi Pasteur. Dr. Zullo is also supported, in part, by grants from the National Institute on Aging (R21AG061632, R01AG065722, RF1AG061221, and R01AG062492) and National Institute of General Medical Sciences (U54GM115677).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Brown University Institutional Review Board approved the study protocol.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Disclaimer: The content and views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs or the United States government.
Data Availability
The data were used under Data Use Agreement with the Centers for Medicare and Medicaid Services and are not available for sharing.
